BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim(TM) Implantable Tibial Nerve Neuromodulator for Overactive Bladder
HERZLIYA, Israel, June 14, 2018 -- (Healthcare Sales & Marketing Network) -- BlueWind Medical, a developer of a miniature wireless neurostimulation platform, for the treatment of multiple clinical indications, announced today that the US Food and Drug Adm... Devices, Urology, Neurology, FDA BlueWind Medical, RENOVA iStim, overactive bladder, Tibial Stimulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Israel Health | Marketing | Middle East Health | Neurology | Overactive Bladder | Overactive Bladder Syndrome | Pharmaceuticals | Urology & Nephrology